| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S109285290001021X |
| P698 | PubMed publication ID | 16155513 |
| P2093 | author name string | Steven R Levine | |
| P2860 | cites work | Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke | Q28167141 |
| Validation of the Sapporo criteria for antiphospholipid syndrome | Q33331606 | ||
| Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy | Q33360325 | ||
| An overview of the heparin-induced thrombocytopenia syndrome | Q33361880 | ||
| Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient). | Q33363184 | ||
| Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests | Q33504233 | ||
| Vascular-bed--specific hemostasis and hypercoagulable states | Q33637363 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Prevalence of Patent Foramen Ovale in Patients with Stroke | Q34049700 | ||
| Diagnostic testing for coagulopathies in patients with ischemic stroke | Q34099965 | ||
| Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. | Q35189292 | ||
| Patent foramen ovale: the missing link between deep venous thrombotic disease and embolic stroke | Q36130974 | ||
| beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program | Q40693493 | ||
| Management of venous thromboembolism | Q41243481 | ||
| Bleeding and thrombosis in myeloproliferative disorders | Q43683330 | ||
| Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke | Q43760186 | ||
| Antiphospholipid antibodies and stroke in young women | Q44168396 | ||
| Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale | Q44269118 | ||
| A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome | Q44588720 | ||
| Hypercoagulability in acute stroke: prognostic significance | Q45250664 | ||
| High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives | Q45887974 | ||
| Ethnic differences in markers of thrombophilia: implications for the investigation of ischemic stroke in multiethnic populations: the South London Ethnicity and Stroke Study | Q46152548 | ||
| Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation. | Q46319995 | ||
| Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosis | Q48398608 | ||
| Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study | Q48657312 | ||
| Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke | Q48955739 | ||
| Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. | Q51026891 | ||
| Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. | Q51547778 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| Antiphospholipid Antibody Syndrome. | Q53330685 | ||
| The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden) | Q61657715 | ||
| Familial thrombophilia is an oligogenetic disease | Q61835548 | ||
| Inherited Antithrombin Deficiency Causing Thrombophilia | Q64386294 | ||
| Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group | Q70514603 | ||
| Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men | Q72596362 | ||
| The management of thrombosis in the antiphospholipid-antibody syndrome | Q72619159 | ||
| Guidelines on the investigation and management of the antiphospholipid syndrome | Q74121684 | ||
| Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses | Q74314212 | ||
| Anticardiolipin antibodies and their associations with cerebrovascular risk factors | Q77398222 | ||
| The prothrombin 20210 G to A variation and thrombosis | Q77424783 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 567-578 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | C N S Spectrums | Q15750260 |
| P1476 | title | Hypercoagulable states and stroke: a selective review | |
| P478 | volume | 10 |
| Q81962689 | Blood coagulation and fibrinolysis: mechanisms of thrombosis |
| Q40328588 | Churg-strauss syndrome as an unusual aetiology of stroke with haemorrhagic transformation in a patient with no cardiovascular risk factors |
| Q96167036 | Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China |
| Q48409860 | Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke. |
| Q36774795 | Increased risk of ischemic stroke in patients with burn injury: a nationwide cohort study in Taiwan |
| Q47159796 | Plasma proteomics reveals coagulation, inflammation, and metabolic shifts in H-type hypertension patients with and without acute ischemic stroke |
| Q33724615 | Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis |
| Q34573328 | Role of investigating thrombophilic disorders in young stroke. |
| Q92542695 | Technology Advancements in Blood Coagulation Measurements for Point-of-Care Diagnostic Testing |
| Q39367273 | The Progress of Epilepsy after Stroke |
| Q38620895 | The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis |
| Q34397567 | Transient ischaemic attack secondary to paraneoplastic erythrocytosis |
Search more.